NCT06224296View on ClinicalTrials.gov

The Exploratory Study About the Effect of Using Double Filtration Plasmapheresis (DFPP) Removing Inflammatory Cytokines, Lipids and Toxic Metal Ions in Peripheral Blood in Adults

NANot yet recruitingINTERVENTIONAL

Enrollment

250

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

March 1, 2025

Conditions

Sub-healthyHyperlipidemiaToxic Metal Ions Accumulation

Interventions

DEVICE

DFPP

One session of blood purification using DFPP to remove inflammatory cytokines in peripheral blood.

DEVICE

DFPP

One session of blood purification using DFPP to remove lipids in peripheral blood.

DEVICE

DFPP

One session of blood purification using DFPP to remove toxic metal ions.

Trial Locations (1)

200240

Shanghai Mengchao Cancer Hospital, Shanghai

All Listed Sponsors

collaborator

Shanghai Mengchao Cancer Hospital

OTHER

lead

Shanghai Cell Therapy Group Co.,Ltd

INDUSTRY

NCT06224296 - The Exploratory Study About the Effect of Using Double Filtration Plasmapheresis (DFPP) Removing Inflammatory Cytokines, Lipids and Toxic Metal Ions in Peripheral Blood in Adults | Biotech Hunter | Biotech Hunter